+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2017-03-10Number of Pages: 155

Veterinary Drugs Market (Product Type - Anti-infective, Anti-inflammatory, and Parasiticides; Animal - Companion and Livestock; Route of Administration - Oral, Parenteral, and Topical) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Global Veterinary Drugs Market: Snapshot

Across developed countries the ownership of companion or livestock animals of various known and exotic breeds has remained high since the last few decades. Developing countries are catching up in this regard as well. Across the world, livestock animals are majorly domesticated for their economic value. Dairy products, meat, fibers, and fertilizers derived from companion animals have considerable market value. In addition, their labor is put to use in agriculture and farming. Besides this, humans have grown fond of petting companion animals. Spurred by these factors the demand for veterinary drugs has increased as veterinarians and owners focus more on ensuring the health and wellness of companion pets.

While the market continues reeling under threat from the availability of low quality counterfeit products, the growing affordability of veterinary drugs will keep their demand pacing higher in the coming years. Given the scenario, Transparency Market Research (TMR) forecasts the market to exhibit a CAGR of 5.1% between 2016 and 2024. At this pace, the market which stood at US$17.2 bn in 2015, is forecast to reach US$26.7 bn by the end of 2024.
veterinary drugs market

Demand for Veterinary Drugs to be Higher in Livestock Animals Segment

In terms of animal type, the global veterinary drugs market is bifurcated into companion animal and livestock animal. Of these, the livestock animal segment held the largest market share in 2015 on account of the high demand for high quality protein and poultry meat. The companion animal segment will exhibit robust growth as well during the course of the forecast period. The rising pet ownership and the increase in healthcare expenditure on them will boost this segment in the coming years.

Based on product, anti-infective, parasiticides, anti-inflammatory, and others comprise the key market segments. Of these, the anti-infective segment held the dominant share in the market in 2015 gaining from the increasing demand for zoonotic diseases. However, between 2016 and 2024, growth witnessed in the parasiticides segment is projected to be higher than other segments. It is forecast to exhibit a CAGR of 6.1% during the forecast period thereby emerging as the most lucrative product segment. The market will witness rising demand for anti-inflammatory drugs as well aimed at improving mobility and quality of life in companion animals.

North America to Continue Dominating Overall Market

Regionally, North America, Latin America, Europe, Asia Pacific, and the Middle East & Africa constitute the key market segments. Among these, North America emerged dominant in 2015, accounting for value-based share of nearly 31%. It is expected to remain at the fore of the overall market through the course of the report’s forecast period. The region exhibits a higher prevalence of pet ownership as compared to other regions. In the same year, Europe emerged as the second-leading market segment. During the forecast period, Asia Pacific and Latin America is also expected to contribute to revenue generated by the overall market. The increasing incidence of infectious disease among animals will fuel the demand for effective veterinary drugs in Asia Pacific and Latin America.

Some of the leading companies operating in the global veterinary drugs market are Zoetis, Inc., which dominated the overall vendor landscape in 2015, Boehringer Ingelheim GmbH, Bayer AG., Elanco Animal Health (Eli Lilly and Company), Ceva Santé Animale, Dechra Pharmaceuticals PLC., Merck & Co., Inc., Virbac, Vetoquinol, and others.

Chapter 1. Preface 
1.1. Report Scope and Market Segmentation 
1.2. Research Highlights

Chapter 2. Assumptions and Research Methodology 
2.1. Assumptions
2.2. Research Methodology

Chapter 3. Executive Summary 
3.1. Global Veterinary Drugs Market : Snapshot, 2015
3.2. Global Veterinary Drugs Market : Opportunity Map

Chapter 4. Market Overview
4.1. Product Overview
4.2. Global Veterinary Drugs Market Size (US$ Mn) Forecast, 2014–2024 
4.3. Global Veterinary Drugs Market Outlook
4.4. Global Veterinary Drugs Market : Key Industry Events
4.5. Global Veterinary Drugs Market : Porter's Analysis
4.6. Key Product Opportunities

Chapter 5. Market Dynamics
5.1. Drivers and Restraints Snapshot Analysis
5.2. Drivers
       5.2.1. Increase in pet ownership & spending on companion animals
       5.2.2. Increased medical and surgical capabilities for companion animals
       5.2.3. Greater emphasis on prevention and wellness by veterinarians and owners
       5.2.4. Evolution of new products to combat emergence of new diseases particularly to cope with zoonotic disease concerns 
       5.2.5. Increased meat consumption and  demand for high quality proteins driving demand for livestock animals
5.3. Restraints
       5.3.1. Lack of novel veterinary drugs in the global market
       5.3.2. Rising concern about the use of antibiotics and growth promoters in food animals
       5.3.3. Prevalence of counterfeit medicines 
5.4. Global Veterinary Drugs Market : Opportunity Analysis
5.5. Opportunities
       5.5.1. Biologics and specialty care offer potential opportunities for players 
       5.5.2. Growing awareness and affordability of drugs for pets and livestock offer significant opportunity to new entrants
5.6. Key Trends
       5.6.1. Launch of generic versions of veterinary drugs by prominent players
       5.6.2. Increase in pet insurance globally
       5.6.3. Targeted in-licensing and strategic acquisitions by leading players
       5.6.4. Viral disease outbreak demands newer medicines every time

Chapter 6. Veterinary Drugs Market Analysis, by Product Type
6.1. Key Findings
6.2. Introduction
6.3. Global Veterinary Drugs Market Value Share Analysis, by Product Type
6.4. Veterinary Drugs Market Analysis, by Product Type 
       6.4.1. Anti-infective
       6.4.2. Anti-inflammatory
       6.4.3. Parasiticides
       6.4.4. Others
6.5. Market Attractiveness Analysis, by Product Type
6.6. Key Trends

Chapter 7. Veterinary Drugs Market Analysis, by Animal Type
7.1. Key Findings
7.2. Introduction
7.3. Global Veterinary Drugs Market Value Share Analysis, by Animal Type
7.4. Veterinary Drugs Market Analysis, by Animal Type
       7.4.1. Companion
       7.4.2. Livestock
7.5. Market Attractiveness Analysis, by Animal Type
7.6. Key Trends

Chapter 8. Veterinary Drugs Market Analysis, by Route of Administration
8.1. Key Findings
8.2. Introduction
8.3. Global Veterinary Drugs Market Value Share Analysis, by Route of Administration
8.4. Veterinary Drugs Market Analysis, by Route of Administration
       8.4.1. Oral
       8.4.2. Parenteral
       8.4.3. Topical
8.5. Market Attractiveness Analysis, by Route of Administration
8.6. Key Trends

Chapter 9. Veterinary Drugs Market Analysis, by Region
9.1. Global Veterinary Drugs Market Snapshot, by Country
9.2. Global Veterinary Drugs Market Value Share Analysis, by Region
9.3. Veterinary Drugs Market Forecast, by Region
9.4. Market Attractiveness Analysis, by Region

Chapter 10. North America Veterinary Drugs Market Analysis
10.1. Key Findings
10.2. Market Overview
10.3. Market Analysis, by Product
       10.3.1. Market Value Share Analysis, by Product
       10.3.2. Market Size (US$ Mn) Forecast, by Product
                 10.3.2.1. Anti-infective
                 10.3.2.2. Anti-inflammatory
                 10.3.2.3. Parasiticides
                 10.3.2.4. Others
10.4. Market Analysis, by Animal
       10.4.1. Market Value Share Analysis, by Animal
       10.4.2. Market Size (US$ Mn) Forecast, by Animal
                 10.4.2.1. Companion
                 10.4.2.2. Livestock
10.5. Market Analysis, by Route of Administration
       10.5.1. Market Value Share Analysis, by Route of Administration
       10.5.2. Market Size (US$ Mn) Forecast, by Route of Administration
                 10.5.2.1. Oral
                 10.5.2.2. Parenteral
                 10.5.2.3. Topical
10.6. Market Analysis, by Country
       10.6.1. Market Value Share Analysis, by Country
       10.6.2. Market Size (US$ Mn) Forecast, by Country, 2016–2024
                 10.6.2.1. U.S.
                 10.6.2.2. Canada
10.7. Market Attractiveness Analysis
       10.7.1. by Product 
       10.7.2. by Animal
       10.7.3. by Route of Administration
       10.7.4. by Country
10.8. Market Trends

Chapter 11. Europe Veterinary Drugs Market Analysis
11.1. Key Findings
11.2. Market Overview
11.3. Market Analysis, by Product
       11.3.1. Market Value Share Analysis, by Product
       11.3.2. Market Size (US$ Mn) Forecast, by Product
                 11.3.2.1. Anti-infective
                 11.3.2.2. Anti-inflammatory
                 11.3.2.3. Parasiticides
                 11.3.2.4. Others
11.4. Market Analysis, by Animal
       11.4.1. Market Value Share Analysis, by Animal
       11.4.2. Market Size (US$ Mn) Forecast, by Animal
                 11.4.2.1. Companion
                 11.4.2.2. Livestock
11.5. Market Analysis, by Route of Administration
       11.5.1. Market Value Share Analysis, by Route of Administration
       11.5.2. Market Size (US$ Mn) Forecast, by Route of Administration
                 11.5.2.1. Oral
                 11.5.2.2. Parenteral
                 11.5.2.3. Topical
11.6. Market Analysis, by Country
       11.6.1. Market Value Share Analysis, by Country
       11.6.2. Market Size (US$ Mn) Forecast, by Country, 2016–2024
                 11.6.2.1. U.K.
                 11.6.2.2. Germany
                 11.6.2.3. Italy
                 11.6.2.4. France
                 11.6.2.5. Spain
                 11.6.2.6. Russia
                 11.6.2.7. Rest of Europe
11.7. Market Attractiveness Analysis
       11.7.1. by Product 
       11.7.2. by Animal
       11.7.3. by Route of Administration
       11.7.4. by Country
11.8. Market Trends

Chapter 12. Asia Pacific Veterinary Drugs Market Analysis
12.1. Key Findings
12.2. Market Overview
12.3. Market Analysis, by Product
       12.3.1. Market Value Share Analysis, by Product
       12.3.2. Market Size (US$ Mn) Forecast, by Product
                 12.3.2.1. Anti-infective
                 12.3.2.2. Anti-inflammatory
                 12.3.2.3. Parasiticides
                 12.3.2.4. Others
12.4. Market Analysis, by Animal
       12.4.1. Market Value Share Analysis, by Animal
       12.4.2. Market Size (US$ Mn) Forecast, by Animal
                 12.4.2.1. Companion
                 12.4.2.2. Livestock
12.5. Market Analysis, by Route of Administration
       12.5.1. Market Value Share Analysis, by Route of Administration
       12.5.2. Market Size (US$ Mn) Forecast, by Route of Administration
                 12.5.2.1. Oral
                 12.5.2.2. Parenteral
                 12.5.2.3. Topical
12.6. Market Analysis, by Country
       12.6.1. Market Value Share Analysis, by Country
       12.6.2. Market Size (US$ Mn) Forecast, by Country, 2016–2024
                 12.6.2.1. China
                 12.6.2.2. Japan
                 12.6.2.3. India
                 12.6.2.4. Australia & New Zealand
                 12.6.2.5. Rest of Asia Pacific
12.7. Market Attractiveness Analysis
       12.7.1. by Product 
       12.7.2. by Animal
       12.7.3. by Route of Administration
       12.7.4. by Country
12.8. Market Trends

Chapter 13. Latin America Veterinary Drugs Market Analysis
13.1. Key Findings
13.2. Market Overview
13.3. Market Analysis, by Product
       13.3.1. Market Value Share Analysis, by Product
       13.3.2. Market Size (US$ Mn) Forecast, by Product
                 13.3.2.1. Anti-infective
                 13.3.2.2. Anti-inflammatory
                 13.3.2.3. Parasiticides
                 13.3.2.4. Others
13.4. Market Analysis, by Animal       
       13.4.1. Market Value Share Analysis, by Animal
       13.4.2. Market Size (US$ Mn) Forecast, by Animal
                 13.4.2.1. Companion
                 13.4.2.2. Livestock
13.5. Market Analysis, by Route of Administration
       13.5.1. Market Value Share Analysis, by Route of Administration
       13.5.2. Market Size (US$ Mn) Forecast, by Route of Administration
                 13.5.2.1. Oral
                 13.5.2.2. Parenteral
                 13.5.2.3. Topical
13.6. Market Analysis, by Country
       13.6.1. Market Value Share Analysis, by Country
       13.6.2. Market Size (US$ Mn) Forecast, by Country, 2016–2024
                 13.6.2.1. Brazil
                 13.6.2.2. Mexico
                 13.6.2.3. Rest of Latin America
13.7. Market Attractiveness Analysis
       13.7.1. by Product 
       13.7.2. by Animal
       13.7.3. by Route of Administration
       13.7.4. by Country
13.8. Market Trends

Chapter 14. Middle East & Africa Veterinary Drugs Market Analysis
14.1. Key Findings
14.2. Market Overview
14.3. Market Analysis, by Product
       14.3.1. Market Value Share Analysis, by Product
       14.3.2. Market Size (US$ Mn) Forecast, by Product
                 14.3.2.1. Anti-infective
                 14.3.2.2. Anti-inflammatory
                 14.3.2.3. Parasiticides
                 14.3.2.4. Others
14.4. Market Analysis, by Animal
       14.4.1. Market Value Share Analysis, by Animal
       14.4.2. Market Size (US$ Mn) Forecast, by Animal
                 14.4.2.1. Companion
                 14.4.2.2. Livestock
14.5. Market Analysis, by Route of Administration
       14.5.1. Market Value Share Analysis, by Route of Administration
       14.5.2. Market Size (US$ Mn) Forecast, by Route of Administration
                 14.5.2.1. Oral
                 14.5.2.2. Parenteral
                 14.5.2.3. Topical
14.6. Market Analysis, by Country
       14.6.1. Market Value Share Analysis, by Country
       14.6.2. Market Size (US$ Mn) Forecast, by Country, 2016–2024
                 14.6.2.1. GCC Countries
                 14.6.2.2. South Africa
                 14.6.2.3. Rest of Middle East & Africa
14.7. Market Attractiveness Analysis
       14.7.1. by Product 
       14.7.2. by Animal
       14.7.3. by Route of Administration
       14.7.4. by Country
14.8. Market Trends

Chapter 15. Company Profiles
15.1. Veterinary Drugs Market Share Analysis, by Company, 2016 (Estimated)
15.2. Competition Matrix
15.3. Company Profiles
       15.3.1. Bayer AG
                 15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
                 15.3.1.2. Financial Overview
                 15.3.1.3. Product Portfolio
                 15.3.1.4. SWOT Analysis
                 15.3.1.5. Strategic Overview
       15.3.2. Boehringer Ingelheim GmbH
                 15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
                 15.3.2.2. Financial Overview
                 15.3.2.3. Product Portfolio
                 15.3.2.4. SWOT Analysis
                 15.3.2.5. Strategic Overview
       15.3.3. Ceva Santé Animale 
                 15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
                 15.3.3.2. Financial Overview
                 15.3.3.3. Product Portfolio
                 15.3.3.4. SWOT Analysis
                 15.3.3.5. Strategic Overview
       15.3.4. Dechra Pharmaceuticals PLC
                 15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
                 15.3.4.2. Financial Overview
                 15.3.4.3. Product Portfolio
                 15.3.4.4. SWOT Analysis
                 15.3.4.5. Strategic Overview
       15.3.5. Eli Lilly and Company (Elanco Animal Health)
                 15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
                 15.3.5.2. Financial Overview
                 15.3.5.3. Product Portfolio
                 15.3.5.4. SWOT Analysis
                 15.3.5.5. Strategic Overview
       15.3.6. Merck Animal Health 
                 15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
                 15.3.6.2. Financial Overview
                 15.3.6.3. Product Portfolio
                 15.3.6.4. SWOT Analysis
                 15.3.6.5. Strategic Overview
       15.3.7. Virbac
                 15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
                 15.3.7.2. Financial Overview
                 15.3.7.3. Product Portfolio
                 15.3.7.4. SWOT Analysis
                 15.3.7.5. Strategic Overview
       15.3.8. Vetoquinol S.A.
                 15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
                 15.3.8.2. Financial Overview
                 15.3.8.3. Product Portfolio
                 15.3.8.4. SWOT Analysis
                 15.3.8.5. Strategic Overview
       15.3.9. Zoetis, Inc. 
                 15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
                 15.3.9.2. Financial Overview
                 15.3.9.3. Product Portfolio
                 15.3.9.4. SWOT Analysis
                 15.3.9.5. Strategic Overview

List of Figures

Figure 1: Global Veterinary Drugs Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2014–2024
Figure 2: Global Veterinary Drugs Market Value Share, by Product Type, 2016 and 2024
Figure 3: Global Anti-infective Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024
Figure 4: Global Anti-inflammatory Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024
Figure 5: Global Parasiticides Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024
Figure 6: Global Others Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024
Figure 7: Global Veterinary Drugs Market Attractiveness Analysis, by Product Type, 2016–2024
Figure 8: Global Veterinary Drugs Market Value Share, by Animal Type, 2016 and 2024
Figure 9: Global Companion Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024
Figure 10: Global Livestock Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024
Figure 11: Global Veterinary Drugs Market Attractiveness Analysis, by Animal Type, 2016–2024
Figure 12: Global Veterinary Drugs Market Value Share, by Route of Administration, 2016 and 2024
Figure 13: Global Oral Route of Administration Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024
Figure 14: Global Parenteral Route of Administration Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024
Figure 15: Global Topical Route of Administration Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024
Figure 16: Global Veterinary Drugs Market Attractiveness Analysis, by Route of Administration, 2016–2024
Figure 17: Global Veterinary Drugs Market Value Share, by Region, 2016 and 2024
Figure 18: Global Veterinary Drugs Market Attractiveness Analysis, by Region, 2016–2024
Figure 19: North America Veterinary Drugs Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2016–2024
Figure 20: North America Veterinary Drugs Market Attractiveness Analysis, by Country
Figure 21: North America Veterinary Drugs Market Value Share, by Product, 2016 and 2024
Figure 22: North America Veterinary Drugs Market Value Share, by Animal Type, 2016 and 2024
Figure 23: North America Veterinary Drugs Market Value Share, by Route of Administration, 2016 and 2024
Figure 24: North America Veterinary Drugs Market Value Share Analysis, by Country, 2016 and 2024
Figure 25: North America Veterinary Drugs Market Attractiveness Analysis, by Product
Figure 26: North America Veterinary Drugs Market Attractiveness Analysis, by Animal Type
Figure 27: North America Veterinary Drugs Market Attractiveness Analysis, by Route of Administration
Figure 28: Europe Veterinary Drugs Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2016–2024
Figure 29: Europe Veterinary Drugs Market Attractiveness Analysis, by Country
Figure 30: Europe Veterinary Drugs Market Value Share, by Product, 2016 and 2024
Figure 31: Europe Veterinary Drugs Market Value Share, by Animal Type, 2016 and 2024
Figure 32: Europe Veterinary Drugs Market Value Share, by Route of Administration, 2016 and 2024
Figure 33: Europe Veterinary Drugs Market Value Share Analysis, by Country, 2016 and 2024
Figure 34: Europe Veterinary Drugs Market Attractiveness Analysis, by Product
Figure 35: Europe Veterinary Drugs Market Attractiveness Analysis, by Animal Type
Figure 36: Europe Veterinary Drugs Market Attractiveness Analysis, by Route of Administration
Figure 37: Asia Pacific Veterinary Drugs Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2016–2024
Figure 38: Asia Pacific Veterinary Drugs Market Attractiveness Analysis, by Country
Figure 39: Asia Pacific Veterinary Drugs Market Value Share, by Product, 2016 and 2024
Figure 40: Asia Pacific Veterinary Drugs Market Value Share, by Animal Type, 2016 and 2024
Figure 41: Asia Pacific Veterinary Drugs Market Value Share, by Route of Administration, 2016 and 2024
Figure 42: Asia Pacific Veterinary Drugs Market Value Share Analysis, by Country, 2016 and 2024
Figure 43: Asia Pacific Veterinary Drugs Market Attractiveness Analysis, by Product
Figure 44: Asia Pacific Veterinary Drugs Market Attractiveness Analysis, by Animal Type
Figure 45: Asia Pacific Veterinary Drugs Market Attractiveness Analysis, by Route of Administration
Figure 46: Latin America Veterinary Drugs Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2016–2024
Figure 47: Latin America Veterinary Drugs Market Attractiveness Analysis, by Country
Figure 48: Latin America Veterinary Drugs Market Value Share, by Product, 2016 and 2024
Figure 49: Latin America Veterinary Drugs Market Value Share, by Animal Type, 2016 and 2024
Figure 50: Latin America Veterinary Drugs Market Value Share, by Route of Administration, 2016 and 2024
Figure 51: Latin America Veterinary Drugs Market Value Share Analysis, by Country, 2016 and 2024
Figure 52: Latin America Veterinary Drugs Market Attractiveness Analysis, by Product
Figure 53: Latin America Veterinary Drugs Market Attractiveness Analysis, by Animal Type
Figure 54: Latin America Veterinary Drugs Market Attractiveness Analysis, by Route of Administration
Figure 55: Middle East & Africa Veterinary Drugs Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2016–2024
Figure 56: Middle East & Africa Veterinary Drugs Market Attractiveness Analysis, by Country
Figure 57: Middle East & Africa Veterinary Drugs Market Value Share, by Product, 2016 and 2024
Figure 58: Middle East & Africa Veterinary Drugs Market Value Share, by Animal Type, 2016 and 2024
Figure 59: Middle East & Africa Veterinary Drugs Market Value Share, by Route of Administration, 2016 and 2024
Figure 60: Middle East & Africa Veterinary Drugs Market Value Share Analysis, by Country, 2016 and 2024
Figure 61: Middle East & Africa Veterinary Drugs Market Attractiveness Analysis, by Product
Figure 62: Middle East & Africa Veterinary Drugs Market Attractiveness Analysis, by Animal Type
Figure 63: Middle East & Africa Veterinary Drugs Market Attractiveness Analysis, by Route of Administration
Figure 64: Global Veterinary Drugs Market Share Analysis, by Company, 2016 (Estimated)

 

List of Tables

Table 1: Global Veterinary Drugs Market Size (US$ Mn) Forecast, by Product Type, 2014–2024
Table 2: Global Veterinary Drugs Market Size (US$ Mn) Forecast, by Animal Type Type, 2014–2024
Table 3: Global Veterinary Drugs Market Size (US$ Mn) Forecast, by Route of Administration, 2014–2024
Table 4: Global Veterinary Drugs Market Size (US$ Mn) Forecast, by Region, 2014–2024
Table 5: North America Veterinary Drugs Market Size (US$ Mn) Forecast, by Product, 2014–2024
Table 6: North America Veterinary Drugs Market Size (US$ Mn) Forecast, by Animal Type, 2014–2024
Table 7: North America Veterinary Drugs Market Size (US$ Mn) Forecast, by Route of Administration, 2014–2024
Table 8: North America Veterinary Drugs Market Size (US$ Mn) Forecast, by Country, 2014–2024
Table 9: Europe Veterinary Drugs Market Size (US$ Mn) Forecast, by Product, 2014–2024
Table 10: Europe Veterinary Drugs Market Size (US$ Mn) Forecast, by Animal Type, 2014–2024
Table 11: Europe Veterinary Drugs Market Size (US$ Mn) Forecast, by Route of Administration, 2014–2024
Table 12: Europe Veterinary Drugs Market Size (US$ Mn) Forecast, by Country, 2014–2024
Table 13: Asia Pacific Veterinary Drugs Market Size (US$ Mn) Forecast, by Product, 2014–2024
Table 14: Asia Pacific Veterinary Drugs Market Size (US$ Mn) Forecast, by Animal Type, 2014–2024
Table 15: Asia Pacific Veterinary Drugs Market Size (US$ Mn) Forecast, by Route of Administration, 2014–2024
Table 16: Asia Pacific Veterinary Drugs Market Size (US$ Mn) Forecast, by Country, 2014–2024
Table 17: Latin America Veterinary Drugs Market Size (US$ Mn) Forecast, by Product, 2014–2024
Table 18: Latin America Veterinary Drugs Market Size (US$ Mn) Forecast, by Animal Type, 2014–2024
Table 19: Latin America Veterinary Drugs Market Size (US$ Mn) Forecast, by Route of Administration, 2014–2024
Table 20: Latin America Veterinary Drugs Market Size (US$ Mn) Forecast, by Country, 2014–2024
Table 21: Middle East & Africa Veterinary Drugs Market Size (US$ Mn) Forecast, by Product, 2014–2024
Table 22: Middle East & Africa Veterinary Drugs Market Size (US$ Mn) Forecast, by Animal Type, 2014–2024
Table 23: Middle East & Africa Veterinary Drugs Market Size (US$ Mn) Forecast, by Route of Administration, 2014–2024
Table 24: Middle East & Africa Veterinary Drugs Market Size (US$ Mn) Forecast, by Country, 2014–2024

Global Veterinary Drug Market: Overview

This report on the veterinary drugs market analyzes the current and future scenario of the global market. Increase in pet ownership, rise in healthcare expenditure on companion animals, rise in meat consumptions along with high demand for good quality proteins are some of the drivers expected to drive the global veterinary drugs market during the forecast period.

The global veterinary drugs market report comprises an elaborate executive summary, which includes market snapshot that provides information about various segments. It also provides information and data analysis of the country’s market with respect to the segments based on product type, animal type, route of administration and regions. A detailed qualitative analysis of drivers and restraints, opportunities, and trends has been provided in the market overview section. Additionally, the section comprises Porters Five Forces Analysis to help understand the competitive landscape in the market. This section also provides market attractiveness analysis in terms of country and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global veterinary drugs market.

Global Veterinary Drug Market: Key Market Segments

Based on product type, the market has been segmented into anti-infective, anti-inflammatory, parasiticides, and others. The market segments have been analyzed based on available approved products, cost-effectiveness, and preference from veterinarians for treating the animals with various drug classes. The market size and forecast for each of these segments have been provided for the period from 2014 to 2024, along with their respective CAGRs for the forecast period from 2016 to 2024, considering 2015 as the base year.

Based on animals, the global veterinary drugs market has been segmented into companion animals and livestock animals. The market segments have been extensively analyzed based on increase in demand for disease treatment among companion animals and livestock animals. Increase in pet ownership, demand for infection free meat, and increase in awareness for treatment of the domesticated animals are driving the market share of animal segment. Different types of route of administration are used to feed the drug to animals. On basis of route of administration global veterinary drugs market is segmented into oral, parenteral, and topical route of administration. Under the route of administration segment, oral administration of drugs in animals plays a major role followed by parenteral. The market size and forecast in terms of US$ Mn for each segment have been provided for the period from 2014 to 2024. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2016 to 2024, considering 2015 as the base year.

Global Veterinary Drugs Market: Regional Outlook

Geographically, the global veterinary drugs market on the basis of region has been segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa. The market size and forecast for each of these regions have been provided for the period from 2014 to 2024, along with their respective CAGRs for the forecast period from 2016 to 2024, considering 2015 as the base year.

Companies Mentioned in Report

The report also profiles major players in the global veterinary drugs market based on various attributes such as company overview, financial overview, product portfolio, business strategies, SWOT analysis, and recent developments. Major players profiled in this report include players in the global veterinary drugs market are Bayer AG., Boehringer Ingelheim GmbH, Ceva Santé Animale, Dechra Pharmaceuticals PLC., Elanco Animal Health (Eli Lilly and Company), Merck & Co., Inc., Virbac, Vetoquinol,  Zoetis, Inc. and others.

The Global Veterinary Drugs Market has been segmented as follows:

Global Veterinary Drugs Market, by Product

  • Anti-infective
  • Anti-inflammatory
  • Parasiticides
  • Others

Global Veterinary Drugs Market, by Animal

  • Companion
  • Livestock

Global Veterinary Drugs Market, by Route of Distribution

  • Oral
  • Parenteral
  • Topical

Global Veterinary Drugs Market, by Geography

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • U.K.
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Japan
    • India
    • China
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC countries
    • South Africa
    • Rest of Middle East & Africa


 
 
Back To Top